Literature DB >> 7212476

Effects of quinidine on serum digoxin concentration: a prospective study.

D R Mungall, R P Robichaux, W Perry, J W Scott, A Robinson, T Burelle, D Hurst.   

Abstract

Results of studies of 15 adults placed on quinidine therapy after their serum digoxin concentrations were stabilized showed significantly increased digoxin concentrations. The average digoxin concentration before quinidine therapy was 0.75 +/- 0.28 ng/mL and after 4 days of quinidine therapy was 1.41 +/- 0.43 ng/mL. During this period, the renal clearance of digoxin decreased from 53.4 +/- 21 mL/min . 1.73 m to 35.3 +/- 12.6 mL/ min . 1.73 m. No significant correlation was found between the individual rise in serum digoxin concentrations and the rise in serum quinidine concentrations. These results suggest that serum digoxin concentration should be monitored closely for at least the first 4 days of quinidine therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7212476     DOI: 10.7326/0003-4819-93-5-689

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

Review 1.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 2.  Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.

Authors:  E M Antman; J M Arnold; P L Friedman; T W Smith
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

Review 3.  Clinical pharmacokinetics in heart failure. An updated review.

Authors:  F V Shammas; K Dickstein
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

Review 4.  The quinidine-digoxin interaction in perspective.

Authors:  B Fichtl; W Doering
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

5.  Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.

Authors:  P J Williams; J Lane; W Murray; M A Mergener; M Kamigaki
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

6.  Decreased renal clearance of digoxin in chronic congestive heart failure.

Authors:  M A Naafs; C van der Hoek; S van Duin; G Koorevaar; W Schopman; J Silberbusch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Renal clearance of digoxin in man after sodium loading or furosemide treatment.

Authors:  M A Naafs; C van der Hoek; W Schopman; S van Duin; G Koorevaar; J Silberbusch
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Effect of quinidine on the digoxin receptor in vitro.

Authors:  W J Ball; D Tse-Eng; E T Wallick; J P Bilezikian; A Schwartz; V P Butler
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle.

Authors:  T Jogestrand; K Schenck-Gustafsson; R Nordlander; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Quinidine and digoxin. An important interaction.

Authors:  J T Bigger; E B Leahey
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.